Avalon GloboCare Teams Up with Weill Cornell Medicine to Co-develop Standardization of cGMP-Grade Exosome Isolation and Application of Tissue-Specific Exosomes

October 10, 2018 Leave a comment 877 Views

Avalon GloboCare Corp, a leading global developer of cell-based technologies and therapeutics, announced today that Weill Cornell Medicine has selected its subsidiary Genexosome Technologies’ proprietary...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: cGMP

Avalon GloboCare Teams Up with Weill Cornell Medicine to Co-develop Standardization of cGMP-Grade Exosome Isolation and Application of Tissue-Specific Exosomes

‘Golden’ exosomes as delivery vehicles to target tumors and overcome intratumoral barriers

Methods for isolation and quantification of exosomes

UTMB team proves potential for reducing pre-term birth by treating fetus with bioengineered exosomes

Exosomes targeted towards applications in regenerative medicine

Research in extracellular vesicles earns Young Investigator Award

New publication details the characterization of novel scaffold proteins that can enable engineered exosomes with defined therapeutic properties